These authors concluded that high levels of Fn were associated with poor prognoses, tumour growth, distant metastasis, poor differentiation, tumour-associated genes (KRAS mutation), and high microsatellite instability in CRC patients [69]. This evidence concerns the gene FN1 and colorectal carcinoma.